NeuBase Therapeutics, Inc. (NBSE) has 18 open-market insider trades by 8 insiders since 2020. The most active filer is Symetryx Corp, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Symetryx Corp | 10% Owner | — | 3 | $1.5M | 2023-09-18 |
| Dov A. Goldstein M.D. | Dir | — | 3 | $158K | 2021-06-18 |
| Dietrich A. Stephan | CEOPres | — | 2 | $120K | 2023-08-02 |
| Eric I. Richman | Dir | — | 3 | $96K | 2022-03-04 |
| Todd P. Branning | CFO | — | 2 | $52K | 2023-03-16 |
| William Roland Mann | COO | — | 2 | $37K | 2022-03-30 |
| Lipizzaner LLC | 10% | — | 2 | $20K | 2020-06-09 |
| Samuel Backenroth | CFOSecretary | — | 1 | $6K | 2020-04-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Symetryx Corp | 10% Owner | Sell | $692K | 2023-09-14 |
| Symetryx Corp | 10% Owner | Sell | $669K | 2023-09-07 |
| Symetryx Corp | 10% Owner | Buy | $120K | 2023-09-01 |
| William Roland Mann | COO | Buy | $12K | 2022-03-30 |
| Todd P. Branning | CFO | Buy | $18K | 2022-03-18 |
| Todd P. Branning | CFO | Buy | $34K | 2022-03-16 |
Companies that share insiders with NBSE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Eric I. Richman | Director | Buy | $6K | 2022-03-01 |
| Dov A. Goldstein M.D. | Director | Buy | $38K | 2021-06-18 |
| Eric I. Richman | Director | Buy | $25K | 2021-04-26 |
| Dov A. Goldstein M.D. | Director | Buy | $60K | 2021-04-26 |
| Lipizzaner LLC | 10% | Buy | $10K | 2020-06-09 |
| Lipizzaner LLC | 10% | Buy | $10K | 2020-05-21 |
| Eric I. Richman | Director | Buy | $65K | 2020-04-30 |
| Dov A. Goldstein M.D. | Director | Buy | $60K | 2020-04-30 |
| Samuel Backenroth | CFO & Secretary | Buy | $6K | 2020-04-30 |